• Profile
Close

Detection rates for benign and malignant diagnoses on breast cancer screening with digital breast tomosynthesis in a Statewide Mammography Registry Study

American Journal of Roentgenology Mar 01, 2019

Fujii MH, et al. - By analyzing observational data from the Vermont Breast Cancer Surveillance System, researchers ascertained if detection rates of specific benign and malignant diagnoses are different for breast cancer screening with digital breast tomosynthesis (DBT) vs full-field digital mammography (FFDM) alone. For this investigation, they performed 86,349 DBT screening examinations and 97,378 FFDM screening examinations at eight radiology facilities in Vermont that adopted DBT screening from 2012–2016. Findings suggested that breast cancer screening with DBT has a lower recall rate compared to FFDM, while finding a comparable distribution of benign and malignant diagnoses.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay